skip to main content

Lowenstein Sandler LLP | The contents of this website contain attorney advertising. | Results may vary depending on your particular facts and legal circumstances.

Search
Smart Search Icon
Header Search

Recent Searches

Clear all Searches

Relevant Insights

Featured Content

view all search results
Search Close
Hamburger
profile Icon for Mobile

Eric Weiner

Partner
Co-chair, Lowenstein Crypto

New York
T: +1 646.414.6940 F: +1 973.597.6151 eweiner@lowenstein.com
  • BIO
  • EXPERIENCE
  • NEWS & INSIGHTS

See more section

Eric Weiner is a partner in Lowenstein Sandler’s Emerging Companies & Venture Capital Group and the Co-Chair of Lowenstein Crypto. He provides strategic counsel to startup and emerging growth companies across all industries and stages, and to the angel, venture, and growth equity funds that invest in them.

Eric represents businesses spanning a wide variety of industries at every phase of their life cycle, from formation to exit and all the stages in between. For over 15 years, he has advised startup companies and venture capital funds on all kinds of transactions, from early stage financings through pre-IPO funding rounds; mergers and acquisitions; and a wide variety of related deals.

Over the last few years, Eric has developed a focus on the crypto market, its founders, and investors: he has advised clients on token rights related to these financings, including negotiations of, and guidance related to, token warrants, token rights agreements, and similar instruments.

Eric is a true partner to his clients and is their “go to” resource on the critical legal and strategic matters facing their businesses. He relishes the long term, trust-based friendships he has formed with them, and takes pride in partnering with his clients on all matters related to their business, from the most simple and small to the most complex and material.

Eric represents clients across the startup ecosystem, including many in the CPG, technology and crypto spaces. Some of his notable representations include theSkimm, Brooklinen, Starface, Vacation, Julie Products, LayerZero Labs, Therapymatch d/b/a Headway, Curie Bio, mParticle, Omsom, Comet ML, Tribute Labs, Floor NFTs, 6th Man Ventures, Anchorage Capital and Hyde Park Venture Partners, to name a few.

Recent Representative Engagements

  • Represented Inductive Bio in $25M Series A financing to transform small molecule drug discovery with industry-wide AI platform
  • Represented Ezra, the healthcare artificial intelligence (AI) company transforming MRI imaging and early cancer detection, in a $21 million fund raise.
  • Represented Inductive Bio, a technology company developing a machine learning (ML) platform designed to accelerate the compound optimization process dramatically, in a $4.3 million Seed Series funding
  • Represented Mercantile, the industry-specific credit card platform designed to meet the unique needs of small businesses, in a $15 million Series A fund raise.
  • Represented LayerZero, a provider of omnichain crypto interoperability networks, in its $135 million Series A round.
  • Represented Woodstock Fund, an emerging technology investment firm focused on early and growth stage distributed ledger technology (DLT) startups and companies, in its most recent investment in Mintbase Inc. an innovative non-fungible token (NFT) platform.
  • Represented Argyle, an employment data platform that provides companies access to user-permissioned employment records in real time, in its Series B Financing.
  • mParticle, Inc. Series E Preferred Stock Financing (and multiple prior venture capital financings)
SEE MORE

Education

  • Benjamin N. Cardozo School of Law (J.D. 2003), cum laude

    New York University (B.A. 1998)

Affiliations

  • Cardozo Startup Clinic - Guest Lecturer

Admissions

  • New York
  • New Jersey

Related Areas

Additional Resources

Additional Resources

Additional Resources

Additional Resources

Subscribe